Electrophoretic mobility shift assays implicate XRCC2:rs3218550C>T as a potential low-penetrant susceptibility allele for sporadic breast cancer

MLA

Nirmala D. Sirisena, et al. “Electrophoretic Mobility Shift Assays Implicate XRCC2:Rs3218550C>T as a Potential Low-Penetrant Susceptibility Allele for Sporadic Breast Cancer.” BMC Research Notes, vol. 12, no. 1, Aug. 2019, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13104-019-4512-9.

APA

Nirmala D. Sirisena, Nilakshi Samaranayake, & Vajira H. W. Dissanayake. (2019). Electrophoretic mobility shift assays implicate XRCC2:rs3218550C>T as a potential low-penetrant susceptibility allele for sporadic breast cancer. BMC Research Notes, 12(1), 1–5. https://doi.org/10.1186/s13104-019-4512-9

Chicago

Nirmala D. Sirisena, Nilakshi Samaranayake, and Vajira H. W. Dissanayake. 2019. “Electrophoretic Mobility Shift Assays Implicate XRCC2:Rs3218550C>T as a Potential Low-Penetrant Susceptibility Allele for Sporadic Breast Cancer.” BMC Research Notes 12 (1): 1–5. doi:10.1186/s13104-019-4512-9.